Drug resistance occurrence is a global healthcare concern responsible for the increased morbidity and mortality in hospitals, time of hospitalisation and huge financial loss. The failure of the most antibiotics to kill Bsuperbugs^poses the urgent need to develop innovative strategies aimed at not only controlling bacterial infection but also the spread of resistance. The prevention of pathogen host invasion by inhibiting bacterial virulence and biofilm formation, and the utilisation of bactericidal agents with different mode of action than classic antibiotics are the two most promising new alternative strategies to overcome antibiotic resistance. Based on these novel approaches, researchers are developing different advanced materials (nanoparticles, hydrogels and surface coatings) with novel antimicrobial properties. In this review, we summarise the recent advances in terms of engineered materials to prevent bacteria-resistant infections according to the antimicrobial strategies underlying their design.
Introduction
Today, antimicrobial resistance (AMR) infections are responsible for 700,000 deaths annually with an economic burden of, only in the USA, over 20 billion dollars per year, and estimations reveal a devastating future by 2050 with ten million deceased per year, unless solutions are found (de Kraker et al. 2016 ). In the last decade, AMR infections have spread from predominantly hospital and care settings environments towards the wider community, endangering the healthcare advances. Antibiotics are crucial in the modern medicine and the loss of effectiveness jeopardises not only the fight against microbial infections such as pneumonia, tuberculosis and malaria, but also turns simple wounds or straightforward surgical procedures into a real menace to life (Jasovský et al. 2016) . Current answers to AMR infections result in higher doses of drugs, treatments with toxic side effects, longer hospital stays and increased mortality (Lee et al. 2013; Ventola 2015) . For instance, colistin, an antibiotic avoided for many years due to renal and neurological damage, is administered as a last resort treatment for patients with resilient Gram-negative bacterial infections (Karaaslan et al. 2016) .
The appearance of antibiotic resistances is a naturally occurring phenomenon via natural selection. The antibiotic induces the environmental pressure and those bacteria able to survive and replicate will be the ones with genes that confer antibiotic resistance. Due to the high bacterial replication rate and the ability to acquire foreign genetic material coding for resistance determinants through horizontal gene transfer, bacteria can rapidly evolve and adapt to the selective antibiotic pressure with a variety of mechanisms including (i) degradation of antibiotics (e.g. beta-lactamase inactivation of penicillins), (ii) modification of the drug target (e.g. mutation of the protein rpsL of the 30S ribosomal subunit, which confers resistance to streptomycin), and (iii) expression of efflux pumps (e.g. AcrAB-TolC pumps which confer resistance to multiple antibiotics as quinolone, chloramphenicol, florfenicol, and tetracycline (TET)) (Baucheron et al. 2004; Carr et al. 2005; Frère 1995; Munita and Arias 2016) . The current overuse of antibiotics has even enhanced the efficacy of these evolving strategies rendering the emergence of bacterial strains resistant to the clinically relevant antibiotics.
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Besides these specific resistance mechanisms, bacteria can adhere to surfaces and grow as biofilms that are tolerant to very high concentrations of multiple antimicrobials. Biofilms comprise a structured and coordinated community of sessile cells embedded within a self-produced extracellular polymeric matrix (Saini et al. 2011) . They can occur on foreign objects inserted into the human body (e.g. orthopaedic prostheses and catheters) as well as in any place in the body where the host defences are compromised (e.g. chronic wounds with impaired blood supply) (Bjarnsholt 2013) . Biofilm-related infections are difficult to treat and frequently require prolonged treatment or alleviate the burden of diseases (Lebeaux et al. 2014) . The high incidence of these infections is related to the progress of the modern medicine and the frequent use of medical devices (Saini et al. 2011; Shorr and Lodise 2006) .
The importance of AMR has fuelled different research initiatives covering from fast diagnostics tools to the design of new drugs and advanced materials that tackle bacterial infections and limit the spread of resistance. The novel antimicrobial approaches aim either to interfere with bacterial virulence and biofilm establishment, enhancing clearance by the host immune system, or eliminate the pathogens through mechanisms, exerting less selective pressure for resistance selection. The present minireview summarises the recent research focus on the development of novel advanced materials, including nanoparticles (NPs), hydrogels and surface coatings that meanwhile display antimicrobial activities towards common pathogens avoid the appearance of AMR (Fig. 1) . Unlike previously published reviews focused in a single type of advanced antimicrobial material (Pelgrift and Friedman 2013; Wang et al. 2017) , this review compiles different innovative antimicrobial materials according to the strategy underlying their design and development.
Inhibition of bacterial virulence and biofilm formation
The virulence of a microorganism refers to the measure of its pathogenicity and is directly related to its ability to invade and multiply within the host, avoid the defence mechanisms and cause disease, thanks to the generation of different molecules called virulence factors. These bacteria-associated determinants are classified in (i) adhesion factors (pili, flagellae, adhesins), (ii) surface components that prevent phagocytosis, (iii) enzymes that damage host tissues known as invasins and (iv) toxins such as pore-forming toxins (PFTs) (Baron 1996) . Once the pathogenic microorganism has avoided clearance by the host immune system and start multiplying, their growth can occur as biofilm. These sessile forms increase the resistance of the pathogenic bacteria to not only the host immune system but also to external agents, such as antibiotics up to 1000 times.
The AMR context has driven researchers in the development of ways to prevent bacterial virulence and growth (as biofilm) without killing, thus avoiding the evolutionary pressure towards resistance mechanisms. The inhibition of bacterial virulence and biofilm growth allow the host defence system to eliminate non-cooperating (and hence less virulent) bacteria or substantially increase the effect of coadministered antibiotics at lower dosages (Brackman et al. 2016; Hentzer and Givskov 2003) . The different strategies to suppress the expression of virulence factors and prevent biofilm growth can be divided into (i) anti-quorum sensing (anti-QS), (ii) anti-toxins and (iii) antibiofouling. These strategies preclude the design and development of different advanced materials (Fig. 1, left side) .
Anti-infective materials with antiquorum sensing activity
As bacteria multiply, secreted small-molecule signals called autoinducers (AIs) accumulate in the extracellular media, and once a threshold is reached, recognition of these signals by membrane receptors activates a regulatory cascade that controls numerous cellular processes. This phenomenon, known as QS, enables single cells to sense the number of bacteria in their environment and when a sufficient number of bacteria is reached, turns on collective behaviours, such as expression of virulence factors and formation of biofilms. Gram-negative bacteria secrete acyl-homoserine lactones (AHLs) that penetrate into the cells and activate the cognate AHL receptor, while Gram-positive bacteria produce autoinducing peptides that interact with a transmembrane histidine kinase receptor, activating the target gene expression via autophosphorylation of the transcriptional regulator (Atkinson and Williams 2009) .
Interruption of QS has become an attractive strategy to suppress the virulence factor secretion and biofilm establishment, increasing bacterial susceptibility to lower dosages of conventional antimicrobials and host immune response (Annous et al. 2009; Cvitkovitch et al. 2003; Davies et al. 1998; Galloway et al. 2010; Li and Tian 2012; Wang et al. 2008) . Anti-QS approaches target the disruption of QS signalling by (i) quorum quenching enzymes (QQEs) degrading the AIs in the extracellular environment and (ii) QS inhibitors (QSIs) competing with QS molecules for binding to the cognate receptors. QQEs, such as acylase and lactonase, selectively inactivate the QS signals in Gram-negative bacteria through the hydrolysis of amide bond or lactone ring in the AHLs, respectively (Craigen et al. 2011; Johansen et al. 1997) . Based on these anti-QS strategies, researchers have generated novel materials to attenuate bacterial virulence and prevent biofilm formation. In our group, the potential of acylase to reduce Pseudomonas aeruginosa biofilm formation on catheters was demonstrated in vitro under conditions mimicking the real situation during catheterisation (Ivanova et al. 2015a ). In another work, the enzyme immobilisation on polyurethane surface resulted also in attenuation of P. aeruginosa virulence (Grover et al. 2016) . Acylase has been used as an antibiofilm agent after chemical and enzymatic immobilisation on carboxylated polyaniline nanofibrer (Lee et al. 2017 ). This QQE was also combined with matrix degrading amylase to impart antibiofilm functionality on catheter surface. The enzymes were deposited in multilayered fashion on silicone material and demonstrated ability to counteract single and dualspecies biofilm formation by P. aeruginosa and Escherichia coli (Ivanova et al. 2015b ). The antibiofilm activity of the coatings was improved by more than 20% when the outermost layer was the QQE, initially affecting bacterial communication. QQE lactonase has been coated onto gold NPs to reduce exopolysaccharide production, metabolic activities, and cell surface hydrophobicity of multidrug-resistant Proteus species (Vinoj et al. 2015) . This QQE has also been immobilised onto magnetic NPs that were also able to hydrolyse AHL and inhibit QS in Gram-negative bacteria (Beladiya et al. 2015) . Lactonase-containing gels inhibited the spread of skin pathogens and considerably increased the mice survival after treatment with antibiotic, at very low amounts (Gupta et al. 2015) . Except the enzymes for QS signal inactivation, other compounds such as antibodies and NPs have been engineered to interfere with bacterial virulence. For example, silicon dioxide NPs functionalised with β-cyclodextrin demonstrated the ability to quench the signals in Vibrio fisheri inhibiting QS regulated gene expression (Miller et al. 2015) .
Innovative anti-QS approaches use analogues of the AIs that recognise and bind with the corresponding bacterial receptors in order to obstruct the QS pathways in Grampositive or Gram-negative bacteria and therefore reduce toxins production or biofilm formation (Frei et al. 2012) . Several anti-QS materials such as nonwoven meshes, tampons or glass surfaces have been coated with cyclic peptides able to disrupt Staphylococcus aureus QS. The QS system of S. aureus was inactivated by 95% when using macrocyclic peptide-loaded carboxymethylcellulose materials. In vitro tests have shown that these anti-QS coatings also prevent the QS-dependent biofilm formation of S. aureus but enabling the normal bacterial growth (Kratochvil et al. 2015) . Natural compounds such as heterocyclic organic furanones alter biofilm formation by hindering QS process. Red algae Delisea pulchra synthesises halogenated furanones as secondary metabolite for bleaching protection. This organic compound also influences the interspecies QS communication on Serratia liquefaciens and Proteus mirabilis altering their biofilm motility Gram et al. 1996) . Furanone (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H) produced by D. pulchra can also alter the swarming motility and biofilm formation of E. coli by interrupting the QS gene regulation (Ren et al. 2001) . Release efficiency of (5Z-)-4-bromo-5-(bromomethylene)-2(5H)-furanone-loaded poly(Llactic acid) (PLLA) NPs coated on dental devices have been shown to be effective for prevention of peri-implant infection (Cheng et al. 2012) . The immobilisation of this furanoneloaded PLLA NPs on microarc-oxidised titanium implants also inhibited S. aureus biofilm formation in the early and intermediate stages (Cheng et al. 2015) .
Synthetic furanones have been designed to improve the otherwise limited effect of the natural furanones on the QS system of P. aeruginosa. These new compounds were tested on mice, and results showed their potential to control bacterial virulence without bactericidal or growth inhibition effect (Wu et al. 2004) . The immobilisation of derivative 3-(1′-bromohexyl)-5-dibromomethylene-2(5 H)-furanone on the styrene polymer or catheter surface significantly reduced Staphylococcus epidermidis formation (Hume et al. 2004 ). Anti-QS compounds were used to develop solid lipid NPs with improved antivirulence activity against P. aeruginosa compared to the free agent (Nafee et al. 2014 ). The QSI Sphenyl-L-cysteine sulfoxide was encapsulated into zein NPs and inhibited Streptococcus mutants biofilm growth (Kasper et al. 2016) . The simultaneous application of either QQE or QSI with antibiotics was shown to significantly attenuate bacterial virulence and inhibit resistant biofilm formation when compared to the active agents alone. This approach opens a new avenue for the development of highly effective antibacterial and antibiofilm materials (Brackman et al. 2011) .
Toxin sequestering materials
Bacterial pathogens produce toxins able to create the optimum conditions for bacterial invasion and growth in the host. The role of toxins in damaging the host tissues, for example, via physical disruption, or modulating the host immune response, such as upregulation of cytokine expression, is well established as part of the infectious processes. Within the framework of antivirulence therapy, the removal of bacterial offensive weapons is of high interest and despite it has been less explored in comparison to the aforementioned strategies, researchers have designed advanced materials with antitoxin properties. Using NPs as decoys for PFTs, scientists have designed and produced the so-called nanosponges, polymeric NP cores coated with intact red blood cell membranes (Hu et al. 2013 ). Thanks to the wrapping membrane, these Bnanosponges^display an ideal mimicry to absorb a wide range of PFTs regardless of their molecular structures. On the other hand, the polymeric core stabilises the membrane shell and prolongs systemic circulation for detoxification in the bloodstream. In further developments, the Bnanospongesĥ ave been integrated in hydrogels for the effective treatment of localised bacterial infection in mouse model through subcutaneous injection . Moreover, a recent work shows how changing the NP coating for macrophage membranes allowed the removal of endotoxins, a lipopolysaccharide released in sepsis, that bounds to macrophages and induce changes in immune cell activity (Thamphiwatana et al. 2017) . Therefore, the membrane-coated NPs open a door to the sequestration of different toxins, based on its cell target, as an attractive alternative to prevent infections. Nevertheless, the removal of toxins is not limited to the use of NPs with biological component, biocompatible synthetic polymer NPs for instance have showed in vivo binding affinity against melitin, a cytolytic peptide from bee venom that forms membrane pores (Henry et al. 2014) . These particles were generated from the combinations of hydrophobic, negatively charged and positively charged monomer library, thus adjusting the ratio of each component for optimum toxin binding. This systematic approach shows potential used for the generation of NPs with specific binding against bacterial toxins.
Antibiofouling materials and surfaces
Indwelling medical devices and implants, once inserted in the human body, create an environment for pathogenic bacteria to adhere and establish biofilms, resulting in severe chronic infection with associated tissue destruction, as well as systemic dissemination of the pathogen. Bacterial adherence occurs at the so-called Bsurface conditioning layer^which is comprised of proteins (e.g. fibronectin, fibrinogen and collagen), lipids, polysaccharides and inorganic salts (Zwaal et al. 1977) . The nonspecific protein adsorption on the inserted device surface triggers the irreversible bacterial attachment (Denstedt et al. 1998; Trautner and Darouiche 2004) . Upon adhesion, bacteria start to grow and expand, forming a small functional community of cells of the same species or other bacterial species and microorganisms (Hung and Henderson 2009) .
Systematic replacement of the contaminated device is not the best option to prevent biofilm-related infections, since only provides a new surface for biofilm establishment (Cole et al. 2014) . However, the functionalisation with broad-spectrum antibacterial agents (e.g. antibiotics, silver and nitric oxide), despite being an active field of research (Evliyaoǧlu et al. 2011; Lellouche et al. 2012; Li et al. 2014) , implies evolutionary stress for selection of resistant bacteria. For these reasons, the design of novel antibacterial and antibiofilm materials aims to inhibit the initial adherence of the free-floating cells and consequently prevent the biofilm formation on the surface of the inserted medical device.
Surface roughness, charge, degree of hydrophobicity, Lewis acid-base character and hydrogen-bonding capacity are the main factors that influence nonspecific reversible microbial attachment, the first step in biofilm growth (Tang et al. 2009 ). Low surface roughness and hydrophobicity decrease cell attachment in different surfaces. Hydrophilic polymers such as poly(ethylene glycol) (PEG), poly(L-glutamic acid), poly(acrylic acid) (PAA) grafted PEG, heparin and hyaluronic acid (HA), have been used to increase the surface hydrophilicity forming a highly hydrated layer that serves as a physical and energy barrier for bacterial adherence (Boulmedais et al. 2004; Fu et al. 2005; Saldarriaga Fernández et al. 2007; Schmolke et al. 2010) . Nanofilms of silver and titanium oxide decreased roughness and hydrophobicity of stain steel orthodontic brackets limiting Streptococcus mutans biofilm formation (Ghasemi et al. 2017) . Fluoroalkylsilane also reduced S. epidermidis adhesion when coated on silicone by reduced roughness and hydrophobicity (Tang et al. 2009 ). Although these reported studies exhibit higher bacterial adhesion on hydrophobic surfaces, other works have concluded that hydrophobic surfaces reduced bacterial adhesion when tested in vivo (Quirynen and Bollen 1995) . Negatively charged surfaces have been reported to prevent biofilm formation due to electrostatic repulsion of the negatively charged bacterial cells. The abovementioned strategy is feasible for temporary materials such as sutures, meshes and drainage tubes, but not very practical to control the occurrence of implant associated infections (Boudou et al. 2010) .
Recently, zwitterionic polymers have appeared as very promising antifouling materials bearing both positively and negatively charged groups (Zhang et al. 2009 ). The adhesion of E. coli and P. mirabilis was reduced on silicone coated with zwitterions phosphorylcholines delaying significantly the biofilm formation compared with uncoated surfaces. The substitution of the phosphorylcholine group by sulfobetaine and carboxybetaine has generated antifouling materials able to prevent microbial and protein adhesion (Chen et al. 2010; Zhang and Chiao 2015) . Immobilisation of zwitterionic poly(carboxybetaine methacrylate) on glass material decreased the adhesion of nonspecific fibrinogen, preventing P. aeruginosa attachment (Cheng et al. 2009 ). Sulfobetaine polymer brushes prevented bovine serum albumin (BSA) adsorption and attachment of E. coli and S. aureus onto a variety of medically relevant surfaces (Guo et al. 2015) . Polysulfobetaine coatings on central venous catheters, generated using a redox polymerisation process, have reduced thrombus aggregation and consequent bacterial attachment better than unmodified catheter surface (Smith et al. 2012) . Poly(sulfobetaine methacrylate) (PSBMA), polyphenol and tannic acid (TA) coatings have been generated in a multilayered fashion forming stable and protein-resistant materials. These (TA/PSBMA) n layers were stable between pH 4-10, and at 0.05 to 1 M sodium chloride and urea solutions. Moreover, 20 bilayers of TA and PSBMA were highly hydrophilic, reducing the adsorption of BSA, lysozyme and haemoglobin . However, these zwitterionic coatings easily dissolve in water, limiting their long-term safe applicability. The introduction of double bonds into the PSBMA structure has generated a more stable antifouling material to coat polyutherane (Wang et al. 2016b ). In our group, sulfobetaine metacrylate monomers were coated on silicone developing urinary catheters with antifouling properties. This coating prevented P. aeruginosa and S. aureus biofilm growth on the urinary catheters longer than their lifetime (Diaz Blanco et al. 2014) . Other strategies involve the degradation of the biofilm extracellular polymeric matrix components, weakening and dispersing the biofilm. The observation that different enzymes can degrade the matrix components of the biofilm with its subsequent dispersion has revealed potential tools to generate antibiofouling and antibiofilm enzyme based materials (Craigen et al. 2011; Johansen et al. 1997) . In this sense, the enzyme deoxyribonuclease I (DNase I) that degrades the extracellular deoxyribonucleic acid (DNA), a key component of P. aeruginosa biofilm matrix, was immobilised on ciprofloxacin-loaded poly(lactic-co-glycolic acid) NPs to reduce the mass, size and living cell density in P. aeruginosa biofilms (Baelo et al. 2015) . Co-immobilisation of DNase I and the antimicrobial peptide (AMP) Palm onto polydimethylsiloxane material, using dopamine chemistry, generated a bifunctional antimicrobial and antibiofilm surface against S. aureus and P. aeruginosa (Alves et al. 2016 ). On the other hand, polysaccharides, another structural component of the biofilm, can also be targeted with the use of enzymes. Dispersin B from Aggregatibacter actinomycetemcomitans, which degrades poly-N-actylglucosamine (Izano et al. 2007) , have been used to generate a silicone surface that inhibits the biofilm of two S. epidermidis clinical strains through its layer-by-layer deposition (Pavlukhina et al. 2012) . Promising antibiofilm activities against Gram-positive and negative pathogenic bacteria have also been observed using a glycosyl hydrolase (Kalpana et al. 2012 ).
Advanced antibacterial materials
The discovery of antimicrobial drugs has revolutionised the medicine and changed the paradigm in treating severe bacterial infections (Munita and Arias 2016) . Their introduction in the clinical practice have made possible the complex medical approaches such as cutting edge surgical procedures, solid organ transplantation and even management of patients with cancer. However, the antibiotics overuse and misuse have led to the appearance of multidrug-resistant pathogens that can survive at unfavourable growth conditions, impeding the successful outcomes of critically ill patients (Cantas et al. 2013 ). The introduction of new antibiotic analogues with similar structural and functional characteristics to the original drug is only a short-term antibacterial strategy. Therefore, there is an urgent need of finding an alternative solution that relies on more than just the development of next-generation antibiotic drugs. In this section, special focus is given on the novel antibiotic alternatives for the development of advanced materials aimed at killing pathogens via nonspecific mechanisms related to membrane damage, oxidative stress and interaction with genetic material and protein, reducing the possibility of resistance development in bacteria. The antibiotic alternatives used to generate the advanced antibacterial materials span from molecules such as enzymes or peptides to polymers and more complex nanostructured materials (Fig. 1, right side) .
Antibacterial enzymes
Besides targeting the degradation or inactivation of essential biofilm components, enzymes may elicit antimicrobial activity through the production of hydrogen peroxide, which destroys the invading pathogens. In general, hydrogen peroxide kills bacterial cells through peroxidation and disruption of cell membranes, oxidation of oxygen scavengers and thiol groups, and disruption of protein synthesis (McDonnell and Russell 1999) . Hydrogen peroxide-producing enzymes such as glucose oxidase and cellobiose dehydrogenase (CDH) can significantly reduce the growth of both Gram-positive and Gramnegative bacteria, and therefore, they are widely exploited in the food industry (Ge et al. 2012; Nyanhongo et al. 2013; Walker et al. 2007 ). CDH oxidises cello-oligosaccharides, which are not considered essential compounds for the pathogens and produce bactericidal hydrogen peroxide. A novel in situ antibacterial approach based on CDH was used to produce hydrogen peroxide in presence of cellobiose or other biofilm exopolysaccharides and inhibit bacterial growth and biofilm formation on silicone catheters. CDH produced by Myriococcum thermophilum inhibited the growth of common urinary pathogens including the multidrug-resistant E. coli, S. aureus, S. epidermidis, P. mirabilis, Stenotrophomonas maltophilia, Acinetobacter baumannii and P. aeruginosa in presence of cellobiose. CDH combination with glycoside hydrolases demonstrated enhanced antimicrobial and antibiofilm activity by the larger amount of released hydrogen peroxide. The enzyme incorporation in lubricants led to significant reduction of bacterial biofilms on catheter surface (Thallinger et al. 2014) . Furthermore, urinary catheters chemically functionalised with antimicrobial CDH, resisted S. aureus biofilm formation under static and dynamic conditions. CDH NP coating onto silicone material have been generated in situ using ultrasound sonochemistry to reduce the amount of viable S. aureus cells and the total biomass on urinary catheters . Myeloperoxidase, lactoperoxidase and haloperoxidase are another type of antibacterial enzymes that use hydrogen peroxide as a substrate to oxidise halide/ pseudohalide to even more active antimicrobials. For instance, horseradish peroxidase and glucose oxidase have been incorporated in polyurethane electrospun fibres that inhibited the E. coli and S. aureus growth (Amitai et al. 2009 ). However, the enzymes may also contribute to the unwanted degradation of biological compounds present in the surrounding of the material.
Besides the biocide-producing enzymes, other examples of enzymes that kill bacteria via different mechanisms have also been reported. Lysostaphin is an antibacterial enzyme acting on the cross-linking pentaglycine bridges in the Staphylococci cell wall. This enzyme has been immobilised onto a variety of surfaces, which were able to kill hospital strains of S. aureus (Yeroslavsky et al. 2015) . Lysostaphin-carbon nanotube conjugates have been developed to reduce protein adsorption and bacterial adhesion (Glinel et al. 2012; Pangule et al. 2010) . Coatings composed of lysozyme, an antibacterial enzyme that degrades the bacterial cell wall, have been designed to inhibit planktonic and sessile growth of Gram-positive and Gramnegative bacteria (Minier et al. 2005; Muszanska et al. 2011; Yuan et al. 2011) . Multilayer constructs of lysozyme and negatively charged gold NPs, DNA or pectin inhibited the growth of different medically relevant bacterial species (Nepal et al. 2008; Zhou et al. 2014) . Although the enzyme-based antibacterial strategies are very promising, the protein activity after surface immobilisation and their in vivo stability and efficacy are the main concerns for further clinical application ).
Antimicrobial peptides
AMPs are oligopeptides with a broad spectrum antibacterial activity towards bacteria, fungi, viruses and parasites (Bahar and Ren 2013) . They interact with the negatively charged bacterial cell membrane, causing membrane disruption or transmembrane pore formation that leads to cell lysis and death (Brogden 2005) . The disruption of bacterial membranes by AMPs is nonspecific, and therefore, the possibility of inducing resistance in bacteria is considerably low. AMPs have been used for development of broad spectrum antibacterial materials and surfaces (Chen et al. 2017; Costa et al. 2011; Holmberg et al. 2013) . For instance, polyurethane catheters coated with AMPs inhibited in vivo planktonic and sessile forms of Gram-positive and Gram-negative bacteria . Antibacterial hydrogels with fast jellification and strong adherence to various medical devices or surfaces have been engineered using the AMP cateslytin (Mateescu et al. 2015) . In another study, HA has been functionalised with the AMP cateslytin and then used to develop self-defensive multilayer coatings (Cado et al. 2013) . A coating of the broad spectrum AMP Tet213, has been assembled onto titanium surface that demonstrated sustained antimicrobial activity and limited early biofilm formation of both a Gram-positive aerobe (S. aureus) and a Gram-negative anaerobe (Porphyromonas gingivalis) for up to 1 month . In another study, homopolymer of methacrylamide bearing (oxidised) 3,4-dihydroxyphenylalanine was used to engineer durable antibacterial-peptide based coatings (Faure et al. 2011; Zhu and Jun Loh 2015) . A stable antimicrobial coating of cecropin-melittin functionalised gold NPs with bactericidal activity towards multidrug-resistant Gram-positive and Gramnegative bacteria has been reported (Rai et al. 2016) . Recently, dual AMP coating has beed engineered via the covalent attachment of the AMP onto hydroxyapatite surface, followed by its electrostatic bounding to effectively prevent S. aureus, S. epidermidis, and P. aeruginosa colonisation over 12 months, while decreasing the side effect to human cells (Townsend et al. 2017) . The main drawbacks limiting the practical application of AMPs is their uncontrolled toxicity, ability to affect the eukaryotic cells, high cost for large-scale synthesis and rapid degradation by the human proteases (Huang et al. 2014 ).
Cationic antibacterial polymers
Cationic compounds including natural or synthetic polymers and lipids have become very attractive antibiotic alternatives in addressing challenges posed by the drug-resistant bacterial infections with decreased potential for resistance development. Antimicrobial polymers have been grafted or self-assembled onto variety of surfaces to interact with the intrinsically anionic bacterial cell wall and cause cell death. Chitosan, the naturally occurring cationic polymer, has been applied on silicon wafer as chitosan/κ-carrageenan multilayers observing an antibacterial activity against clinically relevant Enterococcus faecalis strains (Bratskaya et al. 2007 ). Assemblies of chitosan and anionic lentinan sulphate onto polyurethane surface decreased the pathogenic P. aeruginosa growth, without affecting human cells viability (Wang et al. 2012) . Functional finishing of cotton fabric via the deposition of the oppositely charged chitosan and sodium tripolyphosphate resulted in the successful elimination of both Gram-positive and Gram-negative species (Shirvan et al. 2014) . Nevertheless, the innate cationic charge of chitosan and the differences in assembly conditions, frequently defines the amount of the active agent deposited on the surface, the coating thickness and rigidity, and therefore affects the final antibacterial performance of the material. To overcome these drawbacks, quaternary ammonium salts bearing positive charge independent on the pH have been introduced to design surfaces with better bactericidal properties (Carmona-Ribeiro and de Melo Carrasco 2013; Séon et al. 2015; Tischer et al. 2012) . Quaternary ammonium salt of chitosan have been assembled with PAA on a plasma-treated poly(ethylene terephthalate) to eliminate the E. coli and S. aureus (Graisuwan et al. 2012) . Quaternary ammonium and/or phosphonium salts of pyridoxine, alanine-derived gemini and fatty acids have also been introduced as potent broad spectrum antibiotic alternatives against bacterial pathogens and viruses (Bakhshi et al. 2013; Kayumov et al. 2015; Nikitina et al. 2015; Obłąk et al. 2014; Wong et al. 2010) .
Synthetic polyethers, polymethacrylates, polynorbornenes, polycarbonates and poly-β-lactams polymers have also been developed to mimic the structure of the AMPs and kill bacteria (Engler et al. 2013 ). The introduction of both cationic and hydrophobic moieties into the polymers improves the interaction with bacterial cells, leading to irreparable membrane damage and bacterial death (Paslay et al. 2012; Smriti Rekha et al. 2015) . Triblock polycarbonate polymers composed of antifouling PEG, antimicrobial cationic polycarbonate, and a tethering or adhesive functional block have been synthesised and then covalently grafted on the catheter surface. Depending on the position of the adhesive block, the coatings demonstrated antibacterial and antifouling properties for both Gram-positive S. aureus and Gram-negative E. coli under conditions simulating the device lifetime (1 week) (Voo et al. 2015) . Antimicrobial cationic polycarbonate/PEG hydrogels with strong broad-spectrum antimicrobial activities against clinically isolated multidrug-resistant microbes have been generated (Liu et al. 2012) . The hydrophobicity of the synthetic AMPs mimics is thought to be crucial not only for their antimicrobial activity but also for the toxicity to mammalian cells (Timofeeva and Kleshcheva 2011) . Numerous variations in the cationic−hydrophobic balance have been examined aiming to design antibacterial compounds. Recently, a very different approach for developing membrane active antimicrobials has been reported. This strategy uses spherical and rod-like polymer molecular brushes that mimic the two basic structural motifs of bacteriophages. The polymers induced an unusual topological transition of bacterial but not mammalian membranes to form pores and as such represent a valuable alternative to design advanced materials or surfaces (Jiang et al. 2017 ).
Advanced nanostructured materials
Nanomaterials including NPs, nanospheres and nanocapsules have been widely used in engineering: (i) functional coatings of medical devices and surfaces that prevent bacterial infections and promote healing, (ii) drug carriers for delivering the antibacterial agents at the site of infection and (iii) vaccines. The nano-sized materials possess unique physical and chemical properties and frequently demonstrate improved antibacterial features than their bulk counterparts (Wang et al. 2016a ). Numerous inorganic (e.g. metal and metal oxides) and hybrid (e.g. biopolymer/polymer and metal) NPs have been generated to inhibit planktonic and biofilm growth of medically relevant bacterial strains (Petkova et al. 2014; Sirelkhatim et al. 2015; Wang et al. 2016a Wang et al. , 2017 . The mechanisms underlying the metal NP action, for example, in most cases occur simultaneously and comprise oxidative stress induction, metal ion release, and nonoxidative mechanisms including cell membrane disruption, penetration in bacterial cells and interactions with DNA, ribonucleic acid and proteins (Feng et al. 2000; Pelgrift and Friedman 2013) . The multiple bactericidal mechanisms require multiple simultaneous gene mutations, and therefore for bacteria is very difficult to develop resistance (Pelgrift and Friedman 2013) . For example, silver NPs (AgNPs), synthesised from the cell-free filtrate of fungus Rhizopus Oryzae, were able to interact with bacterial membrane, changing its penetrability (Ramalingam et al. 2016) . In addition, the generated reactive oxygen species (ROS) interfered with the antioxidant defence system in bacteria, leading to damage of the E. coli and P. aeruginosa cell membrane (Ramalingam et al. 2016) . Implants functionalised with antibacterial AgNPs resisted bacterial cell attachment in vivo demonstrating their potential in controlling bacterial infection (Secinti et al. 2011) . ZnO NP-coated medical textiles with durable antibacterial activity towards Gram-positive S. aureus and Gram-negative E. coli have been reported (Petkova et al. 2016) . ZnO and copper oxide (CuO) NPs have been generated to inhibit planktonic or biofilm growth of E. coli, S. aureus, and Bacillus subtilis and fungus Candida albicans via generation of ROS (Eshed et al. 2012) . CuO NPs have been used for the development of broad-spectrum durable antibacterial coating towards E. coli, S. aureus, and kanamycin-resistant E. coli (Li et al. 2017) . Zn-doped CuO NPs with synergistic efficacy towards multidrug-resistant S. aureus and E. coli have been generated in situ and then deposited on silicone catheters (Malka et al. 2013; Shalom et al. 2017) . In another work, ZnO/gold NPs increased ROS levels and demonstrated improved antibacterial activity . Doping the ZnO with fluorine also led in more ROS generation than the ZnO NPs and consequently greater bactericidal activity on S. aureus (99.99%) and E. coli (99.87%) (Podporska-Carroll et al. 2017) . Stable magnesium fluoride (MgF 2 ) NP coatings have been developed on silicone catheters to inhibit the E. coli and S. aureus biofilms . MgF 2 NPs have been further combined with ZnO NPs and synergistically inhibited the resistant biofilm growth of Streptococcus pneumoniae and S. aureus on cochlear implants (Natan et al. 2016) . Antibacterial NPs of cationic biopolymer showed promising antibacterial activities. Thiolated chitosan and aminocellulose NPs showed increased cationic charge density and improved the bactericidal efficacy of the biopolymers towards Gram-negative pathogens . Furthermore, the NP deposition either in layer-by-layer fashion or via chemical grafting onto silicone surface led to stable antibacterial and antibiofilm active coatings (Fernandes et al. 2017a; Francesko et al. 2016) .
Nowadays, the design of hybrid polymer/biopolymer-metal NPs have appeared as an attractive way to improve metal NPs biocompatibility, stability and efficacy in a safety-by-design way (Marambio-Jones and Hoek 2010). PEG-capped ZnO NPs with higher antimicrobial efficacy have been reported. ZnO NPs alone and in combination with the polymer killed the common pathogens and inhibited the resistant biofilm formation (Meruvu et al. 2011) . Medical textiles have been coated with hybrid NPs of ZnO and the biopolymer chitosan to impart higher antibacterial functionality than the individual ZnO and chitosan coatings. Importantly, the inclusion of the biocompatible polymer in the hybrid NP coatings diminished the side effect of the metal to human cells in a safe manner (Petkova et al. 2014) . Polymer-Ag bromide NPs and hydrogels loaded with AgNPs have been generated to completely inhibit the planktonic and biofilm bacterial growth (Agnihotri et al. 2012; Sambhy et al. 2006) . Enzymatically grafted hybrid Ag/chitosan NP coating inhibited S. aureus and E. coli bacterial growth and attachment onto cork surface (Francesko et al. 2015) .
Nevertheless the high antibacterial activity and the improved biocompatibility in vitro, the in vivo application of the aforementioned hybrid nanomaterials is scarcely studied. Nanotransformation of the existing antibiotics could be a facile approach to give new life to these old antibacterials instead of screening for new drugs. Unlike the most common strategies that rely on analogues with similar structural and functional characteristics to the original drug, the nano-sized transformation will improve the actives antibacterial efficacy by a mechanism comprised of a mechanical disruption of bacterial membrane and specific antibiotic activity.
For example, NPs of antibiotics penicillin and vancomycin have been produced using ultrasound sonochemistry. These NPs showed great antibacterial activity against the intrinsically resistant Gram-negative P. aeruginosa and E. coli (Fernandes et al. , 2017b , as well as the clinical isolates of Grampositive S. aureus (Yariv et al. 2015) . The nano-sized transformation of another antibiotic TET also improved its bactericidal activity, killing both TET sensitive and resistant bacteria (Shimanovich et al. 2015) . Sonochemically synthesised graphene oxide/TET nanocomposites demonstrated enhanced activity against both sensitive and resistant S. aureus when compared to the same concentration of nontransformed antibiotic (Mishra et al. 2015) . TET loaded in protein microspheres showed high bactericidal effect against E. coli and S. aureus (Avivi et al. 2003) . Liposomes have also been used as carriers to improve the antibacterial or antibiofilm efficiency of several antibiotics, such as amikacin (Okusanya et al. 2009 ), ciprofloxacin, meropenem and gentamicin (Gubernator et al. 2007 ). However, the effective drug delivery by liposomes, which are composed of membrane phospholipids is a very challenging task, due to drug leakage, temperature sensitivity and short shelf-life. Several studies have shown that superior efficacy of in vivo cellular delivery, enhanced biocompatibility and prolonged circulation time can be achieved by lipid-polymer hybrid NPs compared with delivery without polymeric NPs or by liposomes. For instance, lipid-polymer hybrid NPs of norfloxacin have been prepared to eliminate S aureus and P. aeruginosa (Dave et al. 2017) . Polycarbonate/PEG hydrogels Clinically isolated multidrug-resistant bacteria Liu et al. (2012) 
Conclusions
Overall, the development of effective strategies to fight bacterial infection while limiting the appearance of new drugresistant strains is a very challenging task. Despite we described very promising examples (summarised in Table 1 ), a better understanding of the antibacterial mechanism is required especially within the in vivo context in order to reach the final end users. Within the host environment, the uncontrolled protein adsorption onto the material can modify its physicochemical properties and antimicrobial efficacy by hindering its targeting capacity or inducing rapid clearance. Moreover, most of the highly effective antibacterials show low biocompatibility, which arises the need for development of a new generation of hybrid materials with strong antimicrobial/antifouling activities and improved biocompatibility generated in a Bsafety by design^manner. Finally, considering the bacterial genetic plasticity to evolve rapidly and survive hostile conditions, a deep understanding of how bacteria can overcome the new antimicrobials is necessary to avoid its rapid obsolescence ending up, once again, without responses against resistant bacteria.
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